77 people in Taraba state tested positive to HIV in one week
No less than 77 people have tried positive to Human Immunodeficiency Virus, HIV, last week in Taraba state.
The state organization for the Control of AIDS, revealed this at a week by week survey meeting.
As indicated by the organization, the 77 positive outcomes were gotten from the 2156 people tried across the 16 neighborhood government region of the state the week before.
It further unveiled that the state has 36,396 people presently living with HIV and are additionally getting treatment.
Chief General of the Agency, Dr. Garba Danjuma while talking said new diseases are the significant mishaps to the end of HIV all around the world.
He guaranteed that the organization as a team with improvement accomplices would keep on sharpening inhabitants of the state to decrease new diseases.
As indicated by him, “20,200 of those at present getting treatment are virally stifled.
“Of the 2150 people tried last week, 77 of the outcomes brought positive back.
“76 of the positive cases have additionally been recorded to begin treatment in the wellbeing office nearest to them.”
The improvement accomplices which incorporate Reaching Impact and Saturation Epidemic Control (RISE Nigeria), WHO among others at the gathering likewise developed a plan to shorten the spread of new diseases, particularly in rustic networks.
The Agency had likewise before introduced a HIV/AIDS media backing group to assist the organization with accomplishing its evenhanded of no new diseases of HIV in the state by 2030.
- Benue Government – It’s Difficult To Control Sex In Displaced Persons’ Camp, 80 Babies Born
- APC – Governorship Primary Committee Member Shot In Taraba State
- ASUU Issues Queries To Tertiary Institutions That Pull Out Of Strike
- Kano Assembly clerk— Autonomy for local government will bring an end to insecurity
- Marburg virus outbreak
- Buhari Calls Imo Refinery Deaths National Disaster, Read More Details
Do you find Jalabase useful? Click here to give us five stars rating!
No one has commented yet. Be the first!